Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126766442 | 12676644 | 2 | F | 20160829 | 20160823 | 20160901 | PER | US-PFIZER INC-2016398073 | PFIZER | 0.00 | F | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126766442 | 12676644 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | UNK | U | 20235 | CAPSULE, HARD | |||||||||
| 126766442 | 12676644 | 2 | I | NEURONTIN | GABAPENTIN | 1 | U | 20235 | CAPSULE, HARD | ||||||||||
| 126766442 | 12676644 | 3 | I | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126766442 | 12676644 | 1 | Pain |
| 126766442 | 12676644 | 2 | Neuropathy peripheral |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126766442 | 12676644 | Drug ineffective for unapproved indication | |
| 126766442 | 12676644 | Drug interaction | |
| 126766442 | 12676644 | Drug intolerance | |
| 126766442 | 12676644 | Feeling abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |